Insider Selling: ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) CEO Sells $37,242.00 in Stock
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) CEO Richard E. Lowenthal sold 4,138 shares of the stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $9.00, for a total transaction of $37,242.00. Following the sale, the chief executive officer now directly owns 1,594,328 shares […]
More Stories
Trees Co. (OTCMKTS:CANN) Short Interest Up 108.3% in September
Trees Co. (OTCMKTS:CANN – Get Free Report) saw a large increase in short interest during the month of September. As...
Abrdn Asia-Pacific Income Fund Inc (NYSEAMERICAN:FAX) Short Interest Up 111.3% in September
Abrdn Asia-Pacific Income Fund Inc (NYSEAMERICAN:FAX – Get Free Report) was the recipient of a large increase in short interest...
China Yuchai International Limited (NYSE:CYD) Short Interest Update
China Yuchai International Limited (NYSE:CYD – Get Free Report) was the target of a significant increase in short interest in...
Hang Lung Properties Limited (OTCMKTS:HLPPY) Short Interest Up 126.7% in September
Hang Lung Properties Limited (OTCMKTS:HLPPY – Get Free Report) was the target of a significant growth in short interest during...
Accenture (NYSE:ACN) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Accenture (NYSE:ACN – Get Free Report) announced its earnings results on Thursday. The information technology services provider reported $2.79 EPS...
Short Interest in The Sage Group plc (OTCMKTS:SGPYY) Decreases By 50.0%
The Sage Group plc (OTCMKTS:SGPYY – Get Free Report) was the target of a significant drop in short interest in...